Status:
COMPLETED
Tranexamic Acid Prophylaxis for Heterotopic Ossification in Elbow Fracture-Dislocation Surgery
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Elbow Dislocation
Heterotopic Ossification
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Heterotopic ossification (HO) following elbow fracture-dislocation is a well-recognized condition that can lead to reduced range of motion, increased pain, and the necessity for repeat surgeries. Inf...
Eligibility Criteria
Inclusion
- traumatic non-pathological elbow fracture-dislocation.
- age 18 years or older.
- presentation within 2 weeks of injury.
- Willingness to participate in the study
Exclusion
- Inability to provide consent for research participation.
- Active infection in the operated limb.
- Previous hip fracture.
- Head injury.
- History of deep vein thrombosis (DVT).
- History of venous thromboembolism (VTE).
- Ischemic heart event within the last six months.
- Stroke (CVA) within the last six months.
- Coagulopathies.
- Pregnancy.
Key Trial Info
Start Date :
February 21 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 3 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06088407
Start Date
February 21 2016
End Date
September 3 2023
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf Harofeh Medical Center (Yitzhak Shamir Medical Center)
Be’er Ya‘aqov, Israel, 70300